Introduction
Porphyrins are intermediates of the heme biosynthesis pathway, ranging from eight to four carboxyl groups known as uroporphyrin (8-carboxyl) , hepta, hexa, penta, and coproporphyrin (4-carboxyl), respectively (1) . The predominant porphyrin in urine of healthy individuals is coproporphyrin (copro), followed by uroporphyrin (uro) at minor concentrations (2) . Porphyrias are inherited or acquired metabolic disorders whose clinical cutaneous, neurologic or visceral manifestations are related to characteristic patterns of overproduction of specific heme precursors. There are eight known enzymes involved in heme biosynthesis and enzymatic defects in any subsequent step lead to an excessive excretion of porphyrins and/or their precursors (3) . When clinically active, and in some cases even when latent or in clinical remission, porphyrias induce high levels of heme precursors in blood, urine, and/or stool (1) .
Normal population spot urine porphyrins reference values www.bjournal.com.br Some of the inherited porphyrias occur predominantly as toxicogenetic conditions in which the genetic trait is latent until clinical manifestations of porphyria are triggered idiosyncratically by external factors (1, 4) . These conditions have been observed after exposure to chemicals such as polychlorinated biphenyls (5), hexachlorobenzene (6) , pentachlorophenol (1, 7) , and dioxins (8) and heavy metals such as arsenic (9, 10) , Hg (3), and Pb (11) . They can also occur in individuals infected by some viruses such as HBV (12) , HCV (12) (13) (14) , and HIV (15, 16) or exposed to illicit or therapeutic drugs like alcohol (17) , to prolonged therapeutic use of estrogens (18) and to iron overload (13) , and as adverse effects of drugs like anticonvulsants (19) and anesthetics (20) . In addition, these factors can cause porphyrias in individuals with no documented genetic predisposition as an acquired toxin-induced condition (1, 4) .
Porphyria cutanea tarda is the most common of human porphyrias and results from partial deficiency of the enzyme uroporphyrinogen decarboxylase producing the accumulation of uro and heptacarboxylporphyrins and a predominance of cutaneous symptomatology. It can result from inherited or acquired conditions or a mixture of both (21) .
Disturbances of heme synthesis are associated with alterations of subcellular structure and function that can be related to the clinical signs and symptoms of porphyrias and produce characteristic changes in heme-precursor excretion. These measurable changes offer potential biological markers for detecting the harmful effects of specific chemical exposure while their biological effects are still preclinical and potentially reversible (1, 5) . However, most clinicians, including specialists in occupational and environmental medicine, are relatively uninformed about these phenomena (1) .
Urinary porphyrin excretion is the key tool for the diagnosis of disorders of the heme biosynthesis pathway and, although several spectrofluorometric techniques are available they are not sensitive enough to detect the five fractions (22) . Therefore, the method of choice to determine urinary porphyrin fractions is gradient RP-HPLC using C18 columns with fluorescence detection (22) . In addition to methodological limitations, the interpretation of any laboratory test for porphyrins can be affected by personal factors such as gender, age, occupational activity, smoking and drinking habits (1) .
The purpose of the present study was to determine the normal range values for uro, copro, and uro + copro porphyrin/creatinine ratio in urine samples from healthy volunteers to provide a tool for the early diagnosis of porphyrinopathies and for use as biomarkers of exposure to porphyrinogenic agents. (24) .
Material and Methods

Study population and data collection
Fifteen volunteers were excluded from the study for the following reasons: one for hereditary hemoglobinopathy, which is a known cause of secondary coproporphyrinuria (1); two for presenting urinary creatinine below 0.3 g/L, considered too diluted for proper analysis (24) , and the remaining 12 volunteers for abnormal urinalysis results according to NCCLS standards (23) .
Urinary samples were collected according to standard techniques in the early morning, into polypropylene flasks protected from light. Samples were then separated into two aliquots, one of which was immediately alkalinized with sodium bicarbonate and stored under refrigeration (2-8°C) until porphyrin analysis. The adjustment of concentration-dilution of the spot urine sample was carried out by determining urinary creatinine in the remaining aliquot by the method of Jaffe, as described by Heinegard et al. (25) .
All subjects were also requested to fill out a standardized questionnaire to obtain information about age, place of residence, type of work (technical or administrative), food intake, personal habits (smoking, alcohol intake and hobby activities) and exposure to pharmaceutical drugs in order to provide baseline data for analysis of the risk of the presence of porphyrin in urine.
Urinary porphyrin analysis
Urinary porphyrins and their homologues were analyzed by a high-performance liquid chromatography (HPLC) protocol adapted from the method described by Sunyer et al. (6) , and published by Alves et al. (26) as described below. Chemicals used for buffered phase preparation were of analytical grade. Ammonium acetate, acetic acid and methanol were purchased from Merck AG (Germany). Water was purified using a Milli-Q system from Millipore (USA). Porphyrin standards and controls were purchased from Immundiagnostik (Germany).
Briefly, a 2-mL urine sample was acidified with 70 μL HCl and a 100-μL aliquot was injected into a modular HPLC apparatus (Shimadzu Co., Japan) after 10-min centrifugation at 1500 g and filtration through a 0.45-μm Millipore filter. The HPLC system consisted of two high-pressure pumps (LC-10AD), gradient controller (SCL-10A), auto-sampler (SIL-10A), and fluorescence detector (RF-535, excitation: 400 nm and emission: 620 nm). The sensitivity of the method was 8.0 μg/L for each porphyrin homologue.
All porphyrins were separated on a Lichrosphere 100-RP column (125 x 4 mm) guarded by a Lichrosphere 100-RP (4 x 4 mm) precolumn, both with a particle size of 5 μm and purchased from Merck AG. Flow rate was 1 mL/min. Separation conditions for optimized gradient elution of porphyrins were as follows: mobile phase A consisting of 1.0 M ammonium acetate, pH 4.0, and mobile phase B consisting of 100% methanol. The gradient program for phase B was as follows: isocratic 10% B during the first minute, linear increase from 10 to 95% in the subsequent 12 min and linear decrease from 95 to 10% in the last 3 min.
Statistical analysis
Associations of urinary concentrations of uro, copro and uro + copro porphyrins with the independent variables age, gender, occupational activity, and smoking and drinking habits were analyzed statistically by Mann-Whitney and Kruskal-Wallis tests, when applicable (27, 28) . Bonferroni multiple comparison was further applied to the variables with a significant difference by the Kruskal-Wallis test. The level of significance was set at 0.05 and analyses were performed with the Statistical Package for the Social Sciences (SPSS), version 10.0.
Results
After exclusion criteria were applied with 15 volunteers being excluded, the remaining 126 subjects constituted the study sample (67 women and 59 men). Table 1 describes their demographic characteristics and alcohol intake and smoking habits.
Overall mean ± SD values for uro, copro, and uro + copro porphyrins reported as μg/g urinary creatinine were 5.3 ± 6.0, 42.8 ± 26.4, and 48.1 ± 27.7 μg/g, respectively. Only uro and copro porphyrin fractions could be quantified, with uro + copro porphyrins reported by their sum. Table 2 shows the median, 25-75% range and P values for uro, copro, and uro + copro porphyrins stratified by age, gender, occupational activity, and smoking and drinking habits. Figure 1 shows the total distribution of uro, copro, and uro + copro porphyrins values stratified for the variables with significant differences in Table 2 (professional activity, smoking and drinking habits). Hospital laboratory employees involved in technical activities, when compared to those with administrative functions, presented higher concentrations of urinary copro (median 45.5 vs 30.5 μg/g creatinine, P = 0.004) and uro + copro porphyrins (median 47.3 vs 34.9 μg/g creatinine, P = 0.007). Smokers presented lower values than non-smokers for copro (median 22.5 and 37.2 μg/g creatinine, P = 0.008) and uro + copro porphyrins (median 27.2 and 43.5 μg/g creatinine, P = 0.019). With respect to alcohol consumption, only men showed statistically significant differences (see Table 3 and Figure 1 ) in the levels of copro (P = 0.022) and uro + copro porphyrins (P = 0.012). Bonferroni analysis of these differences showed that individuals with an alcohol consumption >20 g/week had higher copro porphyrin levels compared to those with an alcohol consumption ≤20 g/ week (P = 0.047) and to those with no alcohol consumption Age is reported as means ± SD. Occupational activity, smoking and drinking habit are reported as number of subjects (N).
Normal population spot urine porphyrins reference values www.bjournal.com.br Table 2 . Table 2 . Table 2 . Table 2 . Table 2 . Median and 25th-75th percentiles for uro, copro, and uro + copro porphyrins (μg/g creatinine) and P value for subjects divided into subgroups. Figure 1 . Figure 1 . Figure 1 . Figure 1 . Box-and-whisker plot for urinary levels of uro, copro, and uro + copro porphyrins according to occupational activity and smoking and drinking habits (126 individuals, São Paulo, SP, Brazil). Points are outliers, the box indicates the interquartile range, the whiskers indicate the range, and the horizontal line within the box is the median.
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www.bjournal.com.br at all (P = 0.012). The latter two groups did not differ significantly from one another (see Table 3 ). The same behavior was observed for uro + copro porphyrins, with men with an alcohol consumption >20 g/week having higher levels than those with an alcohol consumption ≤20 g/week (P = 0.038) and those with no alcohol consumption at all (P = 0.009). Again, the latter two groups showed no statistical difference from one another (see Table 3 ). Due to the non-normal distribution of the uro and copro fractions, the 95% confidence intervals (95%CI) were determined by cutting off the 2.5 and 97.5% percentiles, as recommended by Apostoli (29) . The 2.5-97.5th percentiles obtained, excluding subjects who reported more than 20 g/ week of alcohol consumption, were: 0-20.8 μg/g creatinine for uro, 11.7-93.1 creatinine for copro, and 15.9-102.9 μg/ g creatinine for uro + copro porphyrins.
Discussion
The aim of the present investigation was to determine the characteristic profile of urinary porphyrins in spot urine samples from a normal population in order to establish reference values and, therefore, to provide tools for an early diagnosis of porphyrinopathies and to allow the use of these values as biomarkers of exposure to porphyrinogenic agents. Urinary excretion of porphyrins in spot urinary samples has been shown to reflect total daily excretion, avoiding the problems of collecting 24-h specimens (30) . Since porphobilinogen can polymerize to porphyrin or be non-enzymatically converted to porphyrins, it is very important to protect urine samples from light and to store them between 2 and 8°C (2).
Our sample represented a population of highly heterogeneous ethnic origin, as is usual in Brazil. The State of São Paulo receives migrants from different parts of the country, and people of European, Mediterranean, African, and Asian origin are common. Thus, ours was a multiethnic sample living in a city with high-density traffic and in which air pollution is of particular concern, with carbon monoxide, sulfur, nitrogen dioxides, and particulate material measured daily around the city by the São Paulo State Sanitary Agency (CETESB, 2005), and being frequently above the recommended levels (31). Although, to the best of our knowledge, there are no published reports relating air pollutants to urinary porphyrin excretion, we believe that a description of the ethnic and environmental background of our sample would be important for future comparisons with other published results.
The size of our sample (126) met the requirements of the International Federation of Clinical Chemistry (IFCC) (32) and Clinical and Laboratory Standards Institute (CLSI) (33) that recommend at least 120 individuals to estimate the reference range and 95%CI for a new laboratory value to be applied to a healthy population.
Of the five porphyrin fractions known, we were able to quantitatively measure only uro and copro porphyrins in spot urinary samples. The fraction with 7 carboxyl groups was detected in 21/126 individuals (16.5%) of our sample, Table 3 . Table 3 . Table 3 . Table 3 . Table 3 . Median and interquartile interval (25-75%) for urinary copro and uro + copro porphyrins (μg/g creatinine) in male subjects classified into subgroups according to alcohol consumption per week. but its values were below the quantification limit as were fractions with 6 and 5 carboxyl groups. Similar findings have been reported by Sunyer et al. (6), who found the hepta fraction in only 7% of their subjects and also did not detect the other fractions. Our findings for uro (5.3 ± 6.0 μg/g creatinine), copro (41.0 ± 25.2 μg/g creatinine) and uro + copro porphyrins (46.2 ± 26.3 μg/g creatinine) agree with the data reported by Buratti et al. (34) for total porphyrins. Apostoli et al. (10) detected higher values for uro, copro, and uro + copro porphyrins, namely 9.4 ± 11.4, 70.5 ± 36.7, and 89.8 ± 44.8, respectively, using analytical methodology similar to that which we used. The differences found could, therefore, be attributed to the different populations studied.
We found no gender differences in urinary porphyrin profiles, also in agreement with other published reports (35) .
We found that smokers had lower copro and uro + copro porphyrin levels (Table 2 ). However, since only 13.5% of our sample smokes, and there are no published data relating changes in urinary porphyrin excretion to smoking habit, we believe that further studies are needed in order to properly address these findings. Nevertheless, it has been reported that benzopyrene derivatives presented in cigarette smoke can interfere with CYP 450, inducing higher activation of that enzymatic system (36).
Santos et al. (37) found a significant association between alcohol intake and porphyrinuria in non-porphyric adults. Alcohol consumption may trigger a hidden hereditary (or non-hereditary) predisposition to a condition of altered porphyrin metabolism or of overt hepatic porphyria (17) .
We excluded individuals reporting an alcohol consumption >20 g/week from the calculation of the 95%CI presented in this study in order to obtain a proper definition of what could be thought to be the upper reference value for a normal population.
To define new normal laboratory profiles for healthy individuals, establishing reference values related to gender, age and personal habits, plays an important role in population medicine. Furthermore, these values are required for assessing the health status of patients (29) and are a basic tool for biomonitoring programs in occupational and environmental medicine (34) .
Laboratory test results can, in general, be compromised by a variety of factors, including specimen integrity (reflecting conditions of specimen collection, processing, transport and storage), analytical quality control practices and limitations of the analytical methods (37) . Sample protection from light is very important for porphyrin analysis since the fluorescence of porphyrins can decrease if exposed to light (4) .
Although urinary porphyrins are a highly sensitive and specific biomarker for altered heme biosynthesis, they lack specificity for identifying the enzyme, co-factor, etc. responsible for this metabolic alteration. In such cases, some enzyme activities of the heme biosynthetic pathway must be quantified and/or the possible porphyrinogenic agent implicated should be investigated.
The aim of this study was to establish reference values for a healthy population. However, the sample used, 126 subjects, was not large enough to allow multivariate analysis of risk factors associated with alterations in urinary porphyrin excretion. Thus, the study of more subjects will provide more information on other possible risk factors for an altered spot urinary porphyrin profile.
Finally, although the present results were derived only from a sample of the São Paulo city population, we believe they can be used to provide tentative reference levels for other regional studies in Brazil or other countries, and to serve as a proxy to detect slight, but sometimes irreversible, changes in heme biosynthesis.
